Determination of spectinomycin and related substances by HPLC coupled with evaporative light scattering detection

• Autorzy: Wang Y , Wang M. J , Li J. , Yao S. C , Xue J , Zou W. B , Hu C.
• Języki publikacji: EN

Abstrakty

EN

An improved ion-pairing reversed-phase high-performance liquid chromatography method coupled with evaporative light scattering detection (HPLC-ELSD) was developed to determine spectinomycin and its related substances in commercial samples. The method was validated in accordance with International Conference on Harmonization (ICH) guidelines. The specificity of the HPLC-ELSD method was similar to that of the European Pharmacopoeia (Ph. Eur.) method, and repeatability and robustness were markedly improved relative to other reported methods due to our empirical evaluation of separation columns. Indeed, it is a more specific assay of spectinomycin than traditional microbiological techniques. The HPLC-ELSD method was used to evaluate the impurity profiles of eight compounds in seven spectinomycin batches from five different companies. Liquid chromatography coupled with electrospray ionization-tandem mass spectrometry (LC-ESI-MS/MS) was employed to characterize the structures of these compounds. Though the HPLC-ELSD method was not as sensitive as the Ph. Eur. method, its limit of quantitation (LOQ) (0.16%) was lower than the disregard limit (0.3%) described by the Ph. Eur. 7.0. This suggests that the HPLC-ELSD method is appropriate for routine analysis of spectinomycin and its related substances.

Słowa kluczowe

EN

HPLC-ELSD; spectinomycin; related substances; impurity profile

• Wydawca: University of Silesia in Katowice ; Akademiai Kiado
• Czasopismo: Acta Chromatographica
• Rocznik: 2015
• Tom: Vol. 27, no. 1
• Strony: 93--109
• Opis fizyczny: Bibliogr. 37 poz., rys., tab.

Twórcy

autor

Wang Y

• National Institutes for Food and Drug control (NIFDC) Beijing 100050 P.R. China

autor

Wang M. J

• National Institutes for Food and Drug control (NIFDC) Beijing 100050 P.R. China

autor

Li J.

• National Institutes for Food and Drug control (NIFDC) Beijing 100050 P.R. China

autor

Yao S. C

• National Institutes for Food and Drug control (NIFDC) Beijing 100050 P.R. China

autor

Xue J

• National Institutes for Food and Drug control (NIFDC) Beijing 100050 P.R. China
• National Institutes for Food and Drug control (NIFDC) Beijing 100050 P.R. China

autor

Zou W. B

• National Institutes for Food and Drug control (NIFDC) Beijing 100050 P.R. China

autor

Hu C.

• National Institutes for Food and Drug control (NIFDC) Beijing 100050 P.R. China

Bibliografia

• [1] Spectam Oral Solution product information (Vetoquinol-Canada) (2007), www.vetoquinol.ca
• [2] L. Cuerpo and R.C. Livingston, FAO Food Nutr. Pap., 41, 1–86 (1994)
• [3] C.A. Ison A, Genitourin Med., 72, 253–257 (1996)
• [4] J. Hoebus, L.M. Yun, and J. Hoogmartens, Chromatographia, 39, 71–73 (1994)
• [5] J.G. Phillips and C. Simmonds, J. Chromatogr., A, 675, 123–128 (1994)
• [6] M.J. Wang and C.Q. Hu, Chromatographia, 63, 255–260 (2006)
• [7] J.Y. Zhou, L. Zhang, Y. Wang, and C. Yan, J. Sep. Sci., 34, 1811–1819 (2011)
• [8] European Pharmacopoeia, Council of Europe, Strasbourg, 2011, pp. 2969–2971
• [9] N. Haagsma, J.R. Keegstra, and P. Scherpenisse, J. Chromatogr., 615, 289–295 (1993)
• [10] A.A. Bergwerff, P. Scherpenisse, and N. Haagsma, Analyst, 123, 2139–2144 (1998)
• [11] R.E. Hornish and J.R. Wiest, J. Chromatogr., A, 812, 123–133 (1998)
• [12] N. Haagsma, P. Scherpenisse, and R.J. Simmonds, J. Chromatogr., B, 672, 165–171 (1995)
• [13] R.W. Dixon and D.S. Peterson, Anal. Chem., 74, 2930–2937 (2002)
• [14] R.A. Moreau, Lipids, 41, 727–734 (2006)
• [15] A. Joseph, S. Patel, and A. Rustum, J. Chromatogr. Sci., 48, 607–612 (2010)
• [16] K. Stypulkowska, A. Blazewicz, Z. Fijalek, and K. Sarna, Chromatographia, 72, 1225–1229 (2010)
• [17] D. Yan, G. Li, X.H. Xiao, X.P. Dong, and Z.L. Li, J. Chromatogr., A, 1138, 301–304 (2007)
• [18] N. Vervoort, D. Daemen, and G. Torok, J. Chromatogr., A, 1189, 92–100 (2008)
• [19] L. Nováková, S.A. Lopéz, D. Solichová, D. Satínsky, B. Kulichová, A. Horna, and P. Solich Talanta, 78, 834–839 (2009)
• [20] B.J. Goolsby and J.S. Brodbelt, J. Mass Spectrom, 35, 1011–1024 (2000)
• [21] D. Debremaeker, E. Adams, E. Nadal, V.B. Hove, E. Roets, and J. Hoogmartens, J. Chromatogr., A, 953, 123–132 (2002)
• [22] R. Vogel, K. Defillipo, and V. Reif, J. Pharm. Biomed. Anal., 24, 405–412 (2001)
• [23] N.C. Megoulas and M.A. Koupparis, J. Chromatogr., A, 1057, 125–131 (2004)
• [24] A. Clarot, P.I. Storme, P. Chaminade, O. Estevenon, A. Nicolas, and A. Rieutord, J. Chromatogr., A, 50, 64–67 (2009)
• [25] J.W. Hong, C.Q. Hu, and LS Sheng, Acta Pharm. Sin., 38, 695–697 (2003)
• [26] A.K. Sarri, N.C. Megoulas, and M.A. Koupparis, Anal. Chim. Acta, 28, 250–257 (2006)
• [27] N.C. Megoulas and M.A. Koupparis, J. Pharm. Biomed. Anal., 36, 73–79 (2004)
• [28] C.S. Young and J.W. Dolan, LC-GC Eur., 17, 192–201 (2004)
• [29] J. Wang, X.J. Hu, Y. Tu, and K.Y. Ni, J. Chromatogr., B, 834, 178–182 (2006)
• [30] N. Takeda, K. Harada, M. Suzuki, A. Tatematsu, and T. Kubodera, Org. Mass Spectrom., 17, 247–252 (1982)
• [31] S.I. Kotretsou and V.C. Kokotou, Carbohydr. Res., 310, 121–127 (1998)
• [32] B.J. Goolsby and J.S. Brodbelt, J. Mass Spectrom., 35, 1011–1024 (2000)
• [33] P.F. Hu, E.K. Chess, S. Brynjelsen, G.J. Melchert, R.B. Hammond, and T.D. Wilson, J. Am. Soc. Mass Spectrom., 11, 200–209 (2000)
• [34] L.G. McLaughlin and J.D. Henion, J. Chromatogr., 591, 195–206 (1992)
• [35] ICH Harmonised Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology Q2 (R1), Complementary Guideline on Methodology dated 6 November 1996 incorporated in November 2005. http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf
• [36] Pharmacopoeia of the Peopl’s Republic of China Edition 2010, Part II, The State Pharmacopoeia Commission of PR China, Beijing, 2010, pp. 638
• [37] Antibiotics-column Selection Recommendation Database (1, June, 2013), http://www.antibiotic.cn/columnt.htm